Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vivani Medical ( (VANI) ) has shared an update.
On August 11, 2025, Vivani Medical entered into a Share Purchase Agreement to sell 7,936,507 shares of common stock at $1.26 per share, expected to raise approximately $10 million by July 15, 2026. This financing will support the accelerated development of the semaglutide implant NPM-139, following positive preclinical and clinical study results, and secure the company’s financial position into the second half of 2026. Additionally, Vivani plans to spin off its division Cortigent, Inc. as an independent publicly traded company, focusing on brain implant devices.
The most recent analyst rating on (VANI) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on Vivani Medical stock, see the VANI Stock Forecast page.
Spark’s Take on VANI Stock
According to Spark, TipRanks’ AI Analyst, VANI is a Neutral.
Vivani Medical’s overall score reflects its challenging financial situation and unfavorable valuation. Despite some positive corporate events and neutral technical indicators, the company’s consistent losses and reliance on external financing weigh heavily on the score. The strategic focus on core drug implant business and recent milestones offer some potential for improvement, but substantial operational and financial efficiency improvements are necessary for a stronger outlook.
To see Spark’s full report on VANI stock, click here.
More about Vivani Medical
Vivani Medical, Inc. is a biopharmaceutical company that specializes in developing miniaturized, ultra long-acting drug implants using its proprietary NanoPortal™ platform. The company focuses on creating implants for chronic weight management and type 2 diabetes treatment, with products such as the semaglutide implant NPM-139 and exenatide implants NPM-115 and NPM-119.
Average Trading Volume: 142,858
Technical Sentiment Signal: Sell
Current Market Cap: $75.24M
For detailed information about VANI stock, go to TipRanks’ Stock Analysis page.